bioRxivMicrobiology
Utility of cell-free DNA concentrations and illness severity scores to predict survival in critically ill neonatal foals
S. F. Colmer, D. Luethy, M. Abraham, D. Stevanovski, S. D. Hurcombe
Abstract
Plasma cell-free DNA (cfDNA) levels have been associated with disease and survival status in septic humans and dogs. To date, studies investigating cfDNA levels in association with critical illness in foals are lacking. We hypothesized that cfDNA would be detectable in the plasma of foals, that septic and sick-nonseptic foals would have significantly higher cfDNA levels compared to healthy foals, and that increased cfDNA levels would be associated with non-survival. Animals used include 80 foals of 10 days of age or less admitted to a tertiary referral center between January and July, 2020 were stratified into three categories: healthy (n=34), sick non-septic (n=11) and septic (n=35) based on specific criteria. This was a prospective clinical study. Blood was collected from critically ill foals at admission or born in hospital for cfDNA quantification and blood culture. Previously published sepsis score (SS) and neonatal SIRS score (NSIRS) were also calculated. SS, NSIRS, blood culture status and cfDNA concentrations were evaluated to predict survival. Continuous variables between groups were compared using Kruskal-Wallis ANOVA with Dunns post hoc test. Comparisons between two groups were assessed using the Mann-Whitney U-test or Spearman rank for correlations. The performance of cfDNA, sepsis score and NSIRS score to predict survival was assessed by receiver operator characteristic (ROC) curve analysis including area under the curve, sensitivity and specificity using cutoffs. Plasma cfDNA was detectable in all foals. No significant differences in cfDNA concentration were detected between healthy foals and septic foals (P=0.65) or healthy foals and sick non-septic foals (P=0.88). There was no significant association between cfDNA and culture status, SS, NSIRS or foal survival. SS (AUC 0.85) and NSIRS (AUC 0.83) were superior to cfDNA (AUC 0.64) in predicting survival. cfDNA was detectable in foal plasma however offers negligible utility to diagnose sepsis or predict survival in critical illness in neonates.
- organism: non-human primate
- assay: proteomics
- research focus: differential expression
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Bacterial cell-free DNA profiling reveals co-elevation of multiple bacteria in newborn foals with suspected sepsis
Li‐Ting Chen, Emmy Wesdorp, … Jeroen de Ridder·iSciencePeer-reviewed·Nov 13, 2025
- Clinical scoring is the most sensitive biomarker detecting developing sepsis in newborn mice
Beate Fehlhaber, Kathrin Rübensam, … Dorothee Viemann·bioRxiv·May 15, 2018
- Cell-Free DNA in Blood Reveals Significant Cell, Tissue and Organ Specific injury and Predicts COVID-19 Severity
Alexandre Pellan Cheng, Matthew Pellan Cheng, … Iwijn De Vlaminck·MedPeer-reviewed·Jan 18, 2021
- The circulating cell-free DNA landscape in sepsis is dominated by impaired liver clearance
Kiki Cano-Gamez, Patrick Maclean, … Julian Charles Knight·Cell GenomicsPeer-reviewed·Aug 11, 2025
- A neonatal rat sepsis score captures the time course and severity of disease in a clinically relevant rat peritonitis model.
Forough Jahandideh, Si Ning Liu, … Stephane L. Bourque·bioRxiv·May 19, 2026
- What fraction of cellular DNA turnover becomes cfDNA?
Ron Sender, Εlad Noor, … Yuval Dor·eLifePeer-reviewed·Aug 24, 2023